Hide metadata

dc.date.accessioned2016-02-02T10:20:36Z
dc.date.available2016-09-16T22:31:32Z
dc.date.created2015-11-21T00:32:42Z
dc.date.issued2015
dc.identifier.citationPedersen, Kine Sørbye, Sveinung Wergeland Burger, Emily Lönnberg, Stefan Kristiansen, Ivar Sønbø . Using Decision-Analytic Modeling to Isolate Interventions That Are Feasible, Efficient and Optimal: An Application from the Norwegian Cervical Cancer Screening Program.. Value in Health. 2015, 18(8), 1088-1097
dc.identifier.urihttp://hdl.handle.net/10852/48881
dc.description.abstractBackground Decision makers often need to simultaneously consider multiple criteria or outcomes when deciding whether to adopt new health interventions. Objectives Using decision analysis within the context of cervical cancer screening in Norway, we aimed to aid decision makers in identifying a subset of relevant strategies that are simultaneously efficient, feasible, and optimal. Methods We developed an age-stratified probabilistic decision tree model following a cohort of women attending primary screening through one screening round. We enumerated detected precancers (i.e., cervical intraepithelial neoplasia of grade 2 or more severe (CIN2+)), colposcopies performed, and monetary costs associated with 10 alternative triage algorithms for women with abnormal cytology results. As efficiency metrics, we calculated incremental cost-effectiveness, and harm-benefit, ratios, defined as the additional costs, or the additional number of colposcopies, per additional CIN2+ detected. We estimated capacity requirements and uncertainty surrounding which strategy is optimal according to the decision rule, involving willingness to pay (monetary or resources consumed per added benefit). Results For ages 25 to 33 years, we eliminated four strategies that did not fall on either efficiency frontier, while one strategy was efficient with respect to both efficiency metrics. Compared with current practice in Norway, two strategies detected more precancers at lower monetary costs, but some required more colposcopies. Similar results were found for women aged 34 to 69 years. Conclusions Improving the effectiveness and efficiency of cervical cancer screening may necessitate additional resources. Although efficient and feasible, both society and individuals must specify their willingness to accept the additional resources and perceived harms required to increase effectiveness before a strategy can be considered optimal.en_US
dc.languageEN
dc.language.isoenen_US
dc.publisherBlackwell Publishers
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleUsing Decision-Analytic Modeling to Isolate Interventions That Are Feasible, Efficient and Optimal: An Application from the Norwegian Cervical Cancer Screening Program.en_US
dc.typeJournal articleen_US
dc.creator.authorPedersen, Kine
dc.creator.authorSørbye, Sveinung Wergeland
dc.creator.authorBurger, Emily
dc.creator.authorLönnberg, Stefan
dc.creator.authorKristiansen, Ivar Sønbø
cristin.unitcode185,52,11,0
cristin.unitnameAvdeling for helseledelse og helseøkonomi
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode1
dc.identifier.cristin1291650
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Value in Health&rft.volume=18&rft.spage=1088&rft.date=2015
dc.identifier.jtitleValue in Health
dc.identifier.volume18
dc.identifier.issue8
dc.identifier.startpage1088
dc.identifier.endpage1097
dc.identifier.doihttp://dx.doi.org/10.1016/j.jval.2015.08.003
dc.identifier.urnURN:NBN:no-52717
dc.type.documentTidsskriftartikkelen_US
dc.type.peerreviewedPeer reviewed
dc.source.issn1098-3015
dc.identifier.fulltextFulltext https://www.duo.uio.no/bitstream/handle/10852/48881/4/Pedersen2015_ViH_Postprint-edt.pdf
dc.type.versionAcceptedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution-NonCommercial-NoDerivatives 4.0 International
This item's license is: Attribution-NonCommercial-NoDerivatives 4.0 International